RecruitingInterventionalPhase 1Last updated Oct 14, 2025

Dopamine and Sensorimotor Function in Stuttering

Overview

ClinicalTrials.gov ID: NCT07215884
Lead Sponsor: University of California, San FranciscoOTHER
Brief Summary: This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.
Study Type: Interventional

Status

Overall Status: Recruiting
Start Date: Sep 30, 2025Actual
Primary Completion Date: Jun 30, 2026Estimated
Completion Date: Jun 30, 2026Estimated

Study Record Dates

First Submitted: Oct 7, 2025
First Submitted that Met QC Criteria: Oct 8, 2025
First Posted: Oct 14, 2025Actual
Last Update Submitted that Met QC Criteria: Oct 8, 2025
Last Update Posted: Oct 14, 2025Actual
Last Verified: Oct 2025

NCT00024960Completed

Dopamine Function in Developmental Stuttering

NCT01161277Completed

Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning

NCT01684657Suspended

A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering

NCT00953745Completed

Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

NCT07222163Recruiting

Stuttering and Neuromodulation

NCT07180628Recruiting

Organization and Development of Motor Cortical Circuits for Speech Production in Stuttering